CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.

Company profile
Ticker
COO
Exchange
Website
CEO
Albert White
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
COOPER COMPANIES INC
SEC CIK
Corporate docs
Subsidiaries
CooperVision, Inc. • Paragon Vision Sciences, Inc. • Cooper Global Holdings, Inc. • The Cooper Companies Global Holdings LP • CooperVision Global Ltd. • CooperVision International Holding Company, LP • CooperVision do Brasil Ltda • CooperVision Singapore Pte Ltd • CooperVision Optical Trade (Shanghai) Ltd • CVI Contact Lens Pvt. Ltd. ...
IRS number
942657368
COO stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
16 Mar 23
10-Q
2023 Q1
Quarterly report
3 Mar 23
8-K
CooperCompanies Announces First Quarter 2023 Results
2 Mar 23
DEFA14A
Additional proxy soliciting materials
30 Jan 23
DEF 14A
Definitive proxy
30 Jan 23
8-K
Departure of Directors or Certain Officers
19 Dec 22
10-K
2022 FY
Annual report
9 Dec 22
8-K
CooperCompanies Announces Fourth Quarter
8 Dec 22
8-K
CooperCompanies Appoints Cynthia Lucchese to Board of Directors
4 Oct 22
10-Q
2022 Q3
Quarterly report
1 Sep 22
Transcripts
COO
Earnings call transcript
2023 Q1
2 Mar 23
COO
Earnings call transcript
2022 Q4
9 Dec 22
COO
Earnings call transcript
2022 Q3
1 Sep 22
COO
Earnings call transcript
2022 Q2
3 Jun 22
COO
Earnings call transcript
2022 Q1
4 Mar 22
COO
Earnings call transcript
2021 Q4
3 Dec 21
COO
Earnings call transcript
2021 Q3
3 Sep 21
COO
Earnings call transcript
2021 Q2
4 Jun 21
COO
Earnings call transcript
2021 Q1
5 Mar 21
COO
Earnings call transcript
2020 Q4
3 Dec 20
Latest ownership filings
4
GARY S PETERSMEYER
15 Mar 23
4
Gerard H Warner III
9 Mar 23
4
ROBERT S WEISS
7 Mar 23
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 23
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
BlackRock Inc.
7 Feb 23
4
Gerard H Warner III
10 Jan 23
4
Holly R Sheffield
10 Jan 23
4
Agostino Ricupati
10 Jan 23
Financial summary
Quarter (USD) | Jan 23 | Oct 22 | Jul 22 | Apr 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Oct 22 | Oct 21 | Oct 20 | Oct 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 118.50 mm | 118.50 mm | 118.50 mm | 118.50 mm | 118.50 mm | 118.50 mm |
Cash burn (monthly) | 6.70 mm | 13.73 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 12.91 mm | 26.45 mm | n/a | n/a | n/a | n/a |
Cash remaining | 105.59 mm | 92.05 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 15.8 | 6.7 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
98.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 551 |
Opened positions | 84 |
Closed positions | 65 |
Increased positions | 198 |
Reduced positions | 187 |
13F shares | Current |
---|---|
Total value | 16.12 tn |
Total shares | 48.79 mm |
Total puts | 30.32 k |
Total calls | 50.30 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 5.58 mm | $1.85 tn |
BLK Blackrock | 3.81 mm | $1.26 tn |
T. Rowe Price Investment Management | 2.47 mm | $825.43 bn |
STT State Street | 2.11 mm | $696.17 bn |
Veritas Asset Management | 2.09 mm | $691.71 bn |
Generation Investment Management | 1.64 mm | $542.01 bn |
Alliancebernstein | 1.57 mm | $520.06 bn |
BK Bank Of New York Mellon | 1.52 mm | $504.13 bn |
Kayne Anderson Rudnick Investment Management | 1.51 mm | $498.10 bn |
Victory Capital Management | 1.20 mm | $396.37 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Mar 23 | Gerard H Warner III | Common Stock | Sell | Dispose S | No | No | 340.5324 | 1,216 | 414.09 k | 1,290 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 345.906 | 246 | 85.09 k | 70,000 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 344.459 | 772 | 265.92 k | 70,246 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 342.24 | 500 | 171.12 k | 71,018 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 341.154 | 1,986 | 677.53 k | 71,518 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 340.481 | 4,084 | 1.39 mm | 73,504 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 339.48 | 1,963 | 666.40 k | 77,588 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 338.13 | 4,164 | 1.41 mm | 79,551 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 337.199 | 6,053 | 2.04 mm | 83,715 |
7 Mar 23 | Weiss Robert S | Common Stock | Sell | Dispose S | No | No | 336.279 | 12,814 | 4.31 mm | 89,768 |
News
Insiders Selling Perrigo And 3 Other Stocks
10 Mar 23
Cooper Companies Q1 EPS $2.90 Beats $2.69 Estimate, Sales $858.50M Beat $834.62M Estimate
2 Mar 23
Earnings Scheduled For March 2, 2023
2 Mar 23
Cooper Companies's Earnings: A Preview
1 Mar 23
Mizuho Maintains Buy on Cooper Companies, Raises Price Target to $385
24 Jan 23
Press releases
CooperCompanies Announces First Quarter 2023 Results
2 Mar 23
CooperCompanies to Present at KeyBanc Life Sciences & MedTech Investor Forum
28 Feb 23
CooperCompanies to Present at Oppenheimer's 33rd Annual Healthcare Conference
15 Feb 23
Chrissy Teigen Partners with Cord Blood Registry®
8 Feb 23
CooperCompanies Announces Release Date for First Quarter 2023
2 Feb 23